UCLE · As filed with the SEC
US Nuclear balance sheet, by quarter
The statement as US Nuclear presents it in its 10-Q and 10-K: its own lines, labels and order. Tables over time lines up standardized figures across every filing.
Condensed Consolidated Balance Sheets · USD
| USD | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 |
|---|---|---|---|---|
| ASSETS | ||||
| CURRENT ASSETS | ||||
| Cash | 67,318 | 134,779 | 75,907 | 46,285 |
| Accounts receivable, net | 82,745 | 213,700 | 129,945 | 38,533 |
| Note receivable | 38,916 | 39,966 | 51,735 | 40,916 |
| Inventories, net | 1,005,770 | 1,083,083 | 1,704,523 | 1,804,143 |
| Prepaid expenses and other current assets | — | 5,630 | — | — |
| TOTAL CURRENT ASSETS | 1,194,749 | 1,477,158 | 1,962,110 | 1,929,877 |
| Property and equipment, net | — | 524 | 884 | 1,244 |
| Investments | 4,539 | 4,539 | 4,539 | 4,539 |
| Goodwill | 439,662 | 439,662 | 570,176 | 570,176 |
| TOTAL ASSETS | 1,638,950 | 1,921,883 | 2,537,709 | 2,505,836 |
| LIABILITIES AND SHAREHOLDERS’ DEFICIT | ||||
| CURRENT LIABILITIES | ||||
| Accounts payable | 126,820 | 217,440 | 210,235 | 279,511 |
| Accrued liabilities | 1,180,201 | 1,171,321 | 1,116,925 | 1,166,065 |
| Accrued compensation - officers | 31,000 | 13,000 | 13,000 | 13,000 |
| Customer deposit | 65,581 | 117,496 | 292,633 | 302,472 |
| Notes payable, current portion | 234,580 | 181,924 | 97,094 | 152,758 |
| Convertible notes payable, net of debt discount | — | 0 | — | — |
| Note payable to shareholder | 95,561 | 90,330 | 96,812 | 126,512 |
| Line of credit | 452,383 | 384,630 | 409,448 | 410,948 |
| TOTAL CURRENT LIABILITIES | 2,186,126 | 2,176,141 | 2,236,147 | 2,451,266 |
| LONG-TERM LIABILITIES | ||||
| Notes payable, net of current | 117,895 | 184,433 | 155,172 | 805,272 |
| Convertible notes payable | 75,000 | 75,000 | — | — |
| TOTAL LONG-TERM LIABILITIES | 192,895 | 259,433 | 155,172 | 805,272 |
| TOTAL LIABILITIES | 2,379,021 | 2,435,574 | 2,391,319 | 3,256,538 |
| SHAREHOLDERS’ DEFICIT: | ||||
| Common stock, $0.0001 par value; 100,000,000 shares authorized, 62,822,263 and 62,822,263 shares issued and outstanding | 6,283 | 6,283 | 6,139 | 5,995 |
| Common shares to be issued (593,556 shares) | 198,785 | 150,060 | 197,558 | 247,386 |
| Preferred stock, Series A, $0.0001 par value, 10,000 shares authorized, 2,656 and 2,656, issued and outstanding | 266 | 266 | 266 | 201 |
| Additional paid in capital | 20,478,838 | 20,478,838 | 20,408,521 | 19,556,656 |
| Accumulated deficit | (21,424,243) | (21,149,138) | (20,466,094) | (20,560,940) |
| TOTAL SHAREHOLDERS’ DEFICIT | (740,071) | (513,691) | 146,390 | (750,702) |
| TOTAL LIABILITIES AND SHAREHOLDERS’ DEFICIT | 1,638,950 | 1,921,883 | 2,537,709 | 2,505,836 |
As filed on EDGAR · Not affiliated with the U.S. SEC · Not investment advice. Each column links to its filing.